FI791562A - Foerfarande foer framstaellning av 4-amino-2-piperidinokinazolinderivat - Google Patents
Foerfarande foer framstaellning av 4-amino-2-piperidinokinazolinderivatInfo
- Publication number
- FI791562A FI791562A FI791562A FI791562A FI791562A FI 791562 A FI791562 A FI 791562A FI 791562 A FI791562 A FI 791562A FI 791562 A FI791562 A FI 791562A FI 791562 A FI791562 A FI 791562A
- Authority
- FI
- Finland
- Prior art keywords
- piperidinokinazoline
- framstation
- derivatives
- amino
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2035178 | 1978-05-18 | ||
| GB2035178 | 1978-05-18 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI791562A true FI791562A (fi) | 1979-11-19 |
| FI64589B FI64589B (fi) | 1983-08-31 |
| FI64589C FI64589C (fi) | 1983-12-12 |
Family
ID=10144517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI791562A FI64589C (fi) | 1978-05-18 | 1979-05-16 | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-amino-2-piperidinokinazolinderivat |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4243666A (fi) |
| JP (1) | JPS554370A (fi) |
| AR (2) | AR223487A1 (fi) |
| AT (1) | ATA363379A (fi) |
| AU (1) | AU512947B2 (fi) |
| BE (1) | BE876297A (fi) |
| CA (1) | CA1240325A (fi) |
| CH (1) | CH643553A5 (fi) |
| CS (1) | CS214796B2 (fi) |
| DD (1) | DD143613A5 (fi) |
| DE (1) | DE2919800A1 (fi) |
| DK (1) | DK159079A (fi) |
| ES (2) | ES480671A1 (fi) |
| FI (1) | FI64589C (fi) |
| FR (1) | FR2434162A1 (fi) |
| GR (1) | GR72824B (fi) |
| HU (1) | HU182562B (fi) |
| IL (1) | IL57297A (fi) |
| IN (1) | IN153045B (fi) |
| IT (1) | IT1114222B (fi) |
| LU (1) | LU81284A1 (fi) |
| NL (1) | NL172157C (fi) |
| NO (1) | NO791648L (fi) |
| NZ (1) | NZ190465A (fi) |
| PH (1) | PH14802A (fi) |
| PL (2) | PL121158B1 (fi) |
| PT (1) | PT69622A (fi) |
| SE (1) | SE439306B (fi) |
| YU (2) | YU115279A (fi) |
| ZA (1) | ZA792390B (fi) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4607034A (en) * | 1979-10-29 | 1986-08-19 | Mitsubishi Yuka Pharmaceutical Co., Ltd. | Quinazoline derivatives and pharmaceutical composition thereof |
| JPS5962766U (ja) * | 1982-06-30 | 1984-04-25 | 守田 智 | 小動物用給水器 |
| GB8414518D0 (en) * | 1984-06-07 | 1984-07-11 | Pfizer Ltd | Therapeutic agents |
| US5801195A (en) * | 1994-12-30 | 1998-09-01 | Celgene Corporation | Immunotherapeutic aryl amides |
| US6248888B1 (en) | 1997-11-14 | 2001-06-19 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of terazosin hydrochloride dihydrate |
| WO2002057235A1 (fr) * | 2001-01-18 | 2002-07-25 | Takeda Chemical Industries, Ltd. | Procede de preparation de composes de benzylpiperidine |
| US6746460B2 (en) * | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
| JP2007510642A (ja) * | 2003-11-03 | 2007-04-26 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 中枢神経系障害の治療のための新規ノルエピネフリン再取込み阻害薬 |
| WO2008045564A2 (en) * | 2006-10-12 | 2008-04-17 | Epix Delaware, Inc. | Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| KR101441930B1 (ko) * | 2007-04-04 | 2014-09-19 | 시플라 리미티드 | 에르로티닙 및 그의 약학적으로 허용가능한 염의 제조방법 |
| EP2280766A1 (en) * | 2007-12-11 | 2011-02-09 | CytoPathfinder, Inc. | Carboxamide compounds and their use as chemokine receptor agonists |
| BRPI0922010A2 (pt) * | 2008-11-14 | 2015-12-15 | Hoffmann La Roche | dervivados de quinazolina como antagonistas receptores de nk3 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1156973A (en) * | 1965-07-06 | 1969-07-02 | Quinazoline Derivatives | |
| US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
| FR2321890A1 (fr) * | 1975-08-26 | 1977-03-25 | Synthelabo | Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment |
| DK140695C (da) * | 1976-05-07 | 1980-05-12 | Synthelabo | Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf |
-
1979
- 1979-04-18 DK DK159079A patent/DK159079A/da not_active IP Right Cessation
- 1979-05-14 US US06/038,509 patent/US4243666A/en not_active Expired - Lifetime
- 1979-05-16 PL PL1979223844A patent/PL121158B1/pl unknown
- 1979-05-16 CS CS793372A patent/CS214796B2/cs unknown
- 1979-05-16 IN IN337/DEL/79A patent/IN153045B/en unknown
- 1979-05-16 NO NO791648A patent/NO791648L/no unknown
- 1979-05-16 AT AT0363379A patent/ATA363379A/de not_active IP Right Cessation
- 1979-05-16 NZ NZ190465A patent/NZ190465A/xx unknown
- 1979-05-16 BE BE0/195197A patent/BE876297A/xx unknown
- 1979-05-16 AU AU47101/79A patent/AU512947B2/en not_active Ceased
- 1979-05-16 IL IL57297A patent/IL57297A/xx unknown
- 1979-05-16 IT IT22720/79A patent/IT1114222B/it active
- 1979-05-16 GR GR59104A patent/GR72824B/el unknown
- 1979-05-16 PL PL1979215626A patent/PL120651B1/pl unknown
- 1979-05-16 DE DE19792919800 patent/DE2919800A1/de not_active Ceased
- 1979-05-16 AR AR276536A patent/AR223487A1/es active
- 1979-05-16 NL NLAANVRAGE7903853,A patent/NL172157C/xx not_active IP Right Cessation
- 1979-05-16 FI FI791562A patent/FI64589C/fi not_active IP Right Cessation
- 1979-05-16 YU YU01152/79A patent/YU115279A/xx unknown
- 1979-05-16 PH PH22500A patent/PH14802A/en unknown
- 1979-05-17 PT PT69622A patent/PT69622A/pt unknown
- 1979-05-17 JP JP6100079A patent/JPS554370A/ja active Granted
- 1979-05-17 CA CA000327839A patent/CA1240325A/en not_active Expired
- 1979-05-17 SE SE7904358A patent/SE439306B/sv not_active IP Right Cessation
- 1979-05-17 ES ES480671A patent/ES480671A1/es not_active Expired
- 1979-05-17 CH CH459879A patent/CH643553A5/de not_active IP Right Cessation
- 1979-05-17 LU LU81284A patent/LU81284A1/fr unknown
- 1979-05-17 ZA ZA792390A patent/ZA792390B/xx unknown
- 1979-05-17 HU HU79PI678A patent/HU182562B/hu unknown
- 1979-05-17 FR FR7912635A patent/FR2434162A1/fr active Granted
- 1979-05-18 DD DD79213010A patent/DD143613A5/de unknown
-
1980
- 1980-02-01 ES ES488210A patent/ES8101584A1/es not_active Expired
- 1980-10-28 AR AR283021A patent/AR224784A1/es active
-
1982
- 1982-11-16 YU YU02563/82A patent/YU256382A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO790358L (no) | Fremgangsmaate for fremstilling av alkylendiaminderivater | |
| FI800008A (fi) | Foerfarande foer framstaellning av peptidylargininaldehyd-derivat | |
| FI792824A (fi) | Foerfarande foer framstaellning av oxidering inhiberande aemnen | |
| ES494635A0 (es) | Procedimiento de preparacion de derivados de tiadiazol | |
| NO791831L (no) | Fremgangsmaate for fremstilling av aminotiazoler | |
| NO792404L (no) | Fremgangsmaate for fremstilling av imidazolderivater | |
| NO151201C (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater | |
| NO150155C (no) | Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser | |
| NO151895C (no) | Fremgangsmaate for fremstilling av pyrido-indolderivater | |
| NO791139L (no) | Fremgangsmaate for fremstilling av lysergolderivater | |
| FI791562A (fi) | Foerfarande foer framstaellning av 4-amino-2-piperidinokinazolinderivat | |
| SE7902238L (sv) | Forfarande for bestemning av alfa-amylas | |
| NO791604L (no) | Fremangsmaate for fremstilling av di-o-n-alkyl-glycerolderivater | |
| SE7803035L (sv) | Forfarande for framstellning av tienopyridinderivat | |
| NO784382L (no) | Fremgangsmaate for fremstilling av tiazoldin-derivater | |
| SE7707407L (sv) | Forfarande for framstellning av cefamderivat | |
| FI793307A (fi) | Foerfarande foer framstaellning av 6-piperidino-2,4-diaminopyrimidin-3-oxid | |
| FI793221A (fi) | Foerfarande foer framstaellning av substituerade pyrroldiestrar | |
| NO147310C (no) | Fremgangsmaate for fremstilling av substituerte antitumorantracykliner | |
| NO793164L (no) | Fremgangsmaate for fremstilling av natriumamoksycillan | |
| NO791599L (no) | Fremgangsmaate for fremstilling av dibenzyletere | |
| NO152254C (no) | Fremgangsmaate til fremstilling av karbazolderivater | |
| NO794090L (no) | Fremgangsmaate for fremstilling av klordioksyd | |
| NO780389L (no) | Fremgangsmaate for fremstilling av erytromycin-derivater | |
| NO790972L (no) | Fremgangsmaate for isomerisering av derivater av 3-vinyl-piperidin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: PFIZER CORPORATION |